Ndepụta ọgwụ ụra nyocha
Nke a bụ ndepụta nke ọgwụ ụra nyocha, ma ọ bụ ọgwụ ahụ nwere ike ịbelata ọtụtụ ndị na eme ka ndị mmadụ n'ihe ọgwụ maka ọgwụgwọ nke nsogbu ụra nke na-emepe emepe ugbu a maka iji ya eme ihe n'ụlọ ọgwụ mana a kwadoghị ya. A na-edepụta aha kemịkal / n'ozuzu mbụ, na aha koodu mmepe, synonyms, na aha akara na parentheses.

Enweghị ụra

Ndị na-anabata GABAA 

 EVT-201 - GABAA receptor positive allosteric modulator
 Lorediplon (GF-015535-00) - GABAA receptor positive allosteric modulator  
 Zuranolone (SAGE-217) - GABAA receptor positive allosteric modulator

Ndị na-anabata Orexin 

 Seltorexant (MIN-202, JNJ,42847922, JNNJ-922) - onye na-anabata OX2 
 Vornorexant (ORN-0829, TS-142) - OX1 na OX2 receptor antagonist abụọ

Ndị na-anabata Melatonin 

 Piromelatine (Neu-P11) - melatonin receptor agonist na 5-HT1A na 5-HT2D receptor agonists

Nociceptin receptor agonists 

 Sunobinop (IMB-115, IT-1315, S-117957, V-117957) - onye na-anabata nociceptin [1][2]

Hypersleepsy/narcolepsy 

 Danavorexton (TAK-925) - OX2 receptor-selective agonist site na IV infusion[1]
 TAK-994 - OX2 receptor agonist pill (n'ọnụ)

Monoaminergics 

 Flecainide/modafinil (THN-102) - modafinil (dopamine reuptake inhibitor) na flecainide (antiarrhythmic) ngwakọta  
 Mazindol na-achịkwa ntọhapụ (NLS-1001, NLS-1) - norepinephrine-predominant serotonin-norepinephrin-dopamine reuptake inhibitor (SNDRI) [1]
 Reboxetine (AXS-12) - norepinephrine reuptake inhibitor (NRI)

Ndị na-anabata GHB 

 FT-218 (sodium oxybate na-achịkwa ntọhapụ) - GHB na GABAB receptor agonist

Ndị na-egbochi GABAA 

 Pentylenetetrazole (BTD-001) - GABAA receptor negative allosteric modulator

Hụkwa 

 Ndepụta ọgwụ nyocha

Ntụaka